title: Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.
authors.affiliation: University of Miami School of Medicine, Department of Surgery, Florida 33136, USA.
authors.forename: G W
authors.initials: GW
authors.lastname: Burke
authors.forename: G
authors.initials: G
authors.lastname: Ciancio
authors.forename: R
authors.initials: R
authors.lastname: Alejandro
authors.forename: D
authors.initials: D
authors.lastname: Roth
authors.forename: C
authors.initials: C
authors.lastname: Ricordi
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: J
authors.initials: J
authors.lastname: Miller
mesh_terms: D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000379:methods; D011183:Postoperative Complications / Q000453:epidemiology; D011292:Premedication; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008776:Methylprednisolone Hemisuccinate; D009173:Mycophenolic Acid; D016559:Tacrolimus